What Seeds of Innocence does

Seeds of Innocence, legally SEEDS OF INNOCENCE INFERTILITY & MATERNITY CLINIC PRIVATE LIMITED (CIN U85191UP2013PTC058685), is an Indian fertility-clinic chain founded in 2015 by Dr. Gauri Agarwal and Dr. Rajat Arora. It delivers assisted reproductive technology (ART) services — primarily IVF, ICSI, IUI, blastocyst transfer, ovulation induction, and TESA/PESA sperm retrieval — alongside in-house preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), cryopreservation (vitrification of eggs, sperm, and embryos), PRP/ovarian rejuvenation, and minimally invasive gynecologic surgery. The company differentiates by claiming to operate the first IVF centre in India with an in-house genetic testing laboratory and being the only North Indian lab collaborating with the Department of Reproductive Sciences at the University of Gent, Belgium. Its training arm runs a Training Academy offering embryologist, andrology, embryo biopsy, and gynecologic surgical training programs, and its Genestring Labs subsidiary operates molecular, genetic, and pathology diagnostics (including COVID-19 testing at IGI Airport).

The business model is direct-to-consumer healthcare: revenue is generated per treatment cycle at quote-based pricing (Kolkata-published cycles range from ₹80,000 to ₹2,21,000 depending on medications, ICSI, and cryopreservation), with sales conducted through owned IVF centres rather than third-party networks. Go-to-market is multi-channel: appointment booking via website, phone, WhatsApp, and in-person consultation, supported by an active social/SEO presence (YouTube, Instagram, Facebook, LinkedIn), location-targeted blog content, an interactive fertility calculator, and patient testimonial videos. The company reports 35+ IVF centres across 8+ Indian states (Delhi/NCR, Uttar Pradesh, Bihar, Jharkhand, West Bengal, Assam, Uttarakhand, Kerala), with international centres in Muscat (Oman, via Badr Al Samaa partnership) and Lusaka (Zambia), 30+ fertility specialists, 21,000+ documented successful deliveries, and a self-claimed 78% IVF success rate. It is a founder-owned, bootstrapped private company with no disclosed external institutional investment.

Name

Seeds of Innocence

Legal name

SEEDS OF INNOCENCE INFERTILITY & MATERNITY CLINIC PRIVATE LIMITED

Website

https://seedsofinnocens.com

Company type

Private

Founded year

2015

Operating status

Operating

Short description

Seeds of Innocence is an Indian fertility-clinic chain founded in 2015 operating 35+ IVF centres across 8+ states and internationally in Oman and Zambia, offering IVF, ICSI, PGT genetic testing, cryopreservation, and a training academy to couples facing infertility.

Ownership category

akta.pro rank

Product category

Reproductive Medicine / Fertility Clinic Services

NAICS

Family Planning Centers (621410)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Fertility treatments
• IVF services
• Reproductive medicine
• Genetic testing
• Andrology services

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices19 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Fertility Treatment Services: Revenue generated from comprehensive fertility treatments including IVF, ICSI, IUI, blastocyst transfer, ovulation induction, follicular monitoring, egg freezing, and cryopreservation. Services provided across 35+ centres in India and internationally.
2. Genetic Testing Services: In-house genetic testing laboratory providing PGT-A, PGT-M, PGT-SR, and couple carrier screening services
3. Training Academy: Professional training programs for embryologists, andrology technicians, and gynecologic surgeons. Programs include Embryologist Training (3 months/1 year), Andrology Technician Training (1 month), Embryo Biopsy Training (20 days), and Gynecologic Surgical Training (2 weeks to 6 months).
4. Male Fertility Treatments: Specialized male infertility treatments including TESA/PESA sperm retrieval, ICSI, and comprehensive semen analysis services

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Seeds of Innocence operates a network of 35+ fertility clinics (IVF centres) across India and internationally in Oman and Zambia, delivering assisted reproductive technology services such as IVF, ICSI, IUI, blastocyst transfer, and cryopreservation. It also provides preimplantation genetic testing (PGT-A, PGT-M, PGT-SR) through its in-house genetic laboratory, male infertility treatments (TESA/PESA), and runs a Training Academy offering embryologist, andrology, embryo biopsy, and gynecologic surgical training programs.

Product overview

Seeds of Innocence is a fertility clinic chain offering a comprehensive portfolio of assisted reproductive technology services. The core offering includes IVF, IUI, ICSI, genetic testing (PGT-A & PGT-M), blastocyst transfer, cryopreservation, and related fertility treatments. The company operates over 35 IVF centers across India and internationally in Oman and Zambia. The product portfolio also includes specialized male infertility treatments (TESA/PESA), ovulation induction, follicular monitoring, and PRP ovarian rejuvenation. Educational offerings are provided through the Seeds of Innocens Training Academy, offering programs in embryology, andrology, embryo biopsy, and gynecologic surgery. The company also operates Genestring Labs for genetic and molecular diagnostics. The overall offering is structured as a multi-center fertility clinic network with in-house genetic testing capabilities and professional training services.

Differentiator

Problem solved

Functional benefit

Products and services

• In-Vitro Fertilization (IVF) Assisted reproductive technology procedure that retrieves mature eggs and partner sperm, fertilizes them in the laboratory to create embryos, and transfers the resulting embryos into the uterus, designed for couples facing fertility-related problems.
• Intrauterine Insemination (IUI) Simplest form of artificial insemination in which sperm from the male partner is placed directly inside the uterus to increase chances of conception, intended for couples facing mild fertility issues.
• Intracytoplasmic Sperm Injection (ICSI) Advanced micromanipulation technique in which a single sperm is injected directly into an egg for fertilization, particularly effective for male factor infertility and cases requiring TESA/PESA sperm retrieval.
• Preimplantation Genetic Testing (PGT-A & PGT-M) Genetic screening of embryos for aneuploidy (PGT-A) and monogenic inherited disorders (PGT-M) prior to transfer, supported by the company's in-house genetic testing laboratory, intended for couples at risk of chromosomal abnormalities or genetic conditions.
• Blastocyst Transfer Procedure in which embryos are cultured to the blastocyst stage (day 4-5) before being transferred to the uterus, improving embryo selection and implantation potential as part of an IVF cycle.
• Cryopreservation (Egg, Sperm & Embryos) Freezing and long-term storage of eggs, sperm, and embryos at -196°C using vitrification technology, enabling future fertility treatments and fertility preservation.
• Egg Freezing Oocyte cryopreservation process in which eggs are retrieved from the ovaries, frozen via vitrification, and stored for future use, intended for women seeking elective fertility preservation or those facing medical treatments that may affect fertility.
• TESA/PESA Sperm Retrieval Testicular Sperm Aspiration (TESA) and Percutaneous Epididymal Sperm Aspiration (PESA) surgical procedures to retrieve sperm directly from the testicles or epididymis for use in ICSI cycles, designed for men with obstructive or non-obstructive azoospermia.
• Ovulation Induction Process using medications (clomiphene, letrozole, gonadotropins) to stimulate ovulation in women with irregular or absent ovulation, intended as a first-line fertility treatment.
• Follicular Monitoring Ultrasound-based tracking of follicle growth and endometrial development from the start of the menstrual cycle through ovulation to optimize timing for conception or fertility treatments.
• Monitoring in IUI Cycle Ultrasound monitoring of follicular and endometrial development combined with hormone tracking to guide timing of IUI insemination or trigger administration.
• PRP & Ovarian Rejuvenation Platelet-Rich Plasma (PRP) therapy applied to the ovaries to improve ovarian function and fertility outcomes, intended for women with diminished ovarian reserve or age-related fertility decline.
• Male Infertility Treatment Comprehensive diagnostic and treatment services for male factor infertility including semen analysis, sperm retrieval procedures (TESA/PESA), and specialized care for low sperm count, poor motility, abnormal morphology, and obstructive azoospermia.
• Genetic Counseling Genetic counseling service that helps patients understand genetic testing options and limitations and supports informed decision-making about genetic screening within fertility treatments.
• Laparoscopy & Hysteroscopy Minimally invasive laparoscopic and hysteroscopic surgical procedures for diagnosis and treatment of gynecological conditions (such as fibroids, endometriosis, uterine abnormalities) that affect fertility.
• Maternal–Fetal Medicine (MFM) Specialized care service for high-risk pregnancies and fetal health monitoring offered as part of the fertility treatment journey.
• Embryologist Training Program Specialized 3-month or 1-year training program in clinical embryology covering embryo handling, IVF techniques, cryopreservation, and laboratory procedures, intended for life science graduates and embryologists.
• Andrology Technician Training Program 1-month specialized training course covering sperm analysis, semen preparation, cryopreservation, and techniques used in assisted reproductive technology, intended for aspiring andrology technicians.
• Embryo Biopsy Training Program 20-day intensive training for embryologists covering blastomere and trophectoderm biopsy, laser-assisted hatching, and preimplantation genetic testing techniques.
• Gynecologic Surgical Training Program Training program in gynecologic surgical techniques available in durations ranging from 2 weeks to 6 months, intended for gynecologic surgeons seeking specialized surgical skills.

Quantifiable outcome

• 78% success rate in IVF treatments, well above global average
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Department of Reproductive Sciences, University of Gent, BelgiumcoreTechnology or IntegrationOnly lab in North India that has collaborated with the Department of Reproductive Sciences, University of Gent, Belgium, for the exchange of best practices and technology in infertility. This collaboration enables access to international best practices and advanced technologies.
• National University of SingaporecoreStrategic or Co-development PartnerDr. Gauri Agarwal trained in Embryology at National University of Singapore, bringing advanced reproductive technology expertise to the organization.
• Ghent University, BelgiumcoreStrategic or Co-development PartnerDr. Gauri Agarwal completed Fellowship in IVF & ART from Ghent University, Belgium, enabling knowledge transfer of European best practices.
• Stanford University Graduate School of BusinessminorStrategic or Co-development PartnerDr. Gauri Agarwal completed business education at Stanford University Graduate School of Business, bringing management expertise.
• Badr Al Samaa Premium Medical CentrecoreChannel Partner/ Reseller/ DistributorPartnership with Badr Al Samaa Premium Medical Centre in Mabela, Muscat, Oman for hosting the international IVF centre providing fertility services in the Middle East.
• Genestring LabscoreStrategic or Co-development PartnerRelated company providing molecular, genetic, and pathology lab services. Genestring Labs became India's First and Largest Airport Covid-19 testing Lab at IGI International Airport, New Delhi.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Apollo Fertility: Fertility arm of Apollo Hospitals, India's largest hospital chain, leveraging group brand and hospital infrastructure for IVF services. Operates as part of a broader healthcare portfolio rather than fertility-only specialist.
• Fortis Bloom IVF: Fertility centre network operated within Fortis Hospital group, leveraging hospital infrastructure and brand. Provides overlapping IVF/ART services as part of a broader multi-specialty hospital portfolio.

Others

• Genea Biomedx: Australia-based IVF technology and lab-equipment provider serving clinics globally. Comparable as an enabling/ecosystem participant in the ART lab and embryology space Seeds of Innocence operates in.

Direct peers

• Indira IVF: India's largest IVF chain with 100+ centres nationwide, offering the same IVF/ICSI/IUI/PGT service portfolio to infertile couples. Most directly comparable competitor on multi-city clinic-network model and Indian patient demographic.
• Cloudnine Fertility: Hospital-affiliated fertility and maternity provider with multiple centres across India offering IVF and reproductive medicine. Directly comparable on patient segment and service-line overlap, with established brand in maternity care.
• Nova IVF Fertility: Pan-India IVF chain (backed by Asia Healthcare Holdings) with 60+ centres providing IVF, ICSI, IUI, and genetic testing. Directly comparable in scale, service mix, and tier-1/tier-2 expansion strategy.
• Oasis Fertility: South-India-headquartered fertility chain expanding nationally with IVF, ICSI, and andrology services. Comparable on clinic-network model and patient demographic.
• Birla Fertility & IVF: CK Birla Group-backed fertility chain rapidly expanding across India with full ART service portfolio. Directly comparable in clinical offerings and aggressive multi-city growth; well-capitalised competitor.
• Morpheus IVF: India-headquartered international IVF chain with centres across India and the Middle East. Directly comparable on cross-border patient model and full-service ART offering.

Regional players

• Medicover Fertility: European-headquartered fertility chain with India and international presence offering IVF, ICSI, and genetic testing. Comparable on service mix and medical-tourism patient model, though primary footprint outside India.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@seedsofinnocens
• Facebookfacebook.com/seedsofinnocens
• LinkedInlinkedin.com/company/seedsofinnocens
• Instagraminstagram.com/seedsofinnocensivf
• Xx.com/seedsofinnocens

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seeds of Innocence